iron protein succinylate

01/01/2002 - "[Legofer--a new approach in the treatment of iron deficiency. "
05/01/1993 - "A prospective, open, multicenter clinical trial was set up to evaluate the potential interaction of ITF 282 with H2-receptor antagonists in patients affected with iron deficiency. "
04/01/1993 - "Controlled, double-blind, multicenter clinical trial of iron protein succinylate in the treatment of iron deficiency in children."
03/01/1993 - "Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1,000 patients."
05/01/1990 - "[Ferroprotein succinylate: treatment of iron deficiency in obstetrics and gynecology]."

01/01/2005 - "Iron protein succinylate is an effective and well tolerated treatment of iron-deficiency anemia in pregnancy."
01/01/2005 - "The aim of this study was to evaluate the efficacy and tolerability of iron protein succinylate in the treatment of iron-deficiency anemia in pregnancy. "
01/01/1984 - "Pharmacological and toxicological studies on an iron succinyl-protein complex (ITF282) for oral treatment of iron deficiency anemia."
01/01/2005 - "The efficacy and tolerability of iron protein succinylate in the treatment of iron-deficiency anemia in pregnancy."
12/01/2002 - "[Iron protein-succinylate in the treatment of adult iron-deficiency anemia]."

11/01/1995 - "During the 60-day treatment, both ITF 282 and the reference drugs induced the most significant increase in Hb in the patients affected by the most severe anemia. "
12/01/2013 - "To evaluate the efficacy and safety of iron protein succinylate (IPS) oral solution in preventing and treating anemia of prematurity (AOP). "
12/01/2013 - "[Clinical study of iron protein succinylate oral solution for preventing and treating anemia of prematurity]."
01/01/2020 - ": Although all iron treatments analyzed are effective and safe, our results suggest that iron protein succinylate may be an excellent choice to treat iron deficiency and anemia due to its superior effectiveness and tolerability."
06/01/1998 - "One-hundred children, 48 males and 52 females, mean age +/- SD 39.9 +/- 28.2 months (range 12 to 113) with sideropenia or sideropenic anemia were randomly divided into 2 groups of 50 patients each (groups A and B) and were treated with iron protein succinylate (group A) or iron hydroxide polymaltose complex (group B). "

01/01/2009 - "The aim of this study was to compare the efficacy, safety and achievement of the target hemoglobin level (Hb >or=10 g/dl) in patients with preoperative anemia due to menorrhagia who received intravenous iron sucrose compared with oral iron protein succinylate for anemia management. "

05/01/1993 - "The general tolerability was apparently more favorable in the patients who had also the antiulcer (1 event of diarrhoea) than in those who had ITF 282 alone (2 heartburn, 3 constipation, 2 abdominal pain). "